Pradhan A: Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev. 2007, 65 (12 Pt 2): S152-156. 10.1111/j.1753-4887.2007.tb00354.x.
PubMed
Google Scholar
Launer LJ: Next steps in Alzheimer's disease research: interaction between epidemiology and basic science. Curr Alzheimer Res. 2007, 4 (2): 141-143. 10.2174/156720507780362155.
CAS
PubMed
Google Scholar
Wang XP, Ding HL: Alzheimer's disease: epidemiology, genetics, and beyond. Neurosci Bull. 2008, 24 (2): 105-109. 10.1007/s12264-008-0105-7.
PubMed
Google Scholar
de la Monte SM, Neusner A, Chu J, Lawton M: Epidemilogical Trends Strongly Suggest Exposures as Etiologic Agents in the Pathogenesis of Sporadic Alzheimer's Disease, Diabetes Mellitus, and Non-Alcoholic Steatohepatitis. J Alzheimers Dis. 2009, 17 (3): 519-529.
CAS
PubMed
PubMed Central
Google Scholar
Swann PF, Magee PN: Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate. Biochem J. 1968, 110 (1): 39-47.
CAS
PubMed
PubMed Central
Google Scholar
Espey MG, Miranda KM, Thomas DD, Xavier S, Citrin D, Vitek MP, Wink DA: A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann N Y Acad Sci. 2002, 962: 195-206. 10.1111/j.1749-6632.2002.tb04068.x.
CAS
PubMed
Google Scholar
Pasquier F, Boulogne A, Leys D, Fontaine P: Diabetes mellitus and dementia. Diabetes Metab. 2006, 32 (5 Pt 1): 403-414. 10.1016/S1262-3636(07)70298-7.
CAS
PubMed
Google Scholar
Nicolls MR: The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. Curr Alzheimer Res. 2004, 1 (1): 47-54. 10.2174/1567205043480555.
CAS
PubMed
Google Scholar
Yeh MM, Brunt EM: Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol. 2007, 128 (5): 837-847. 10.1309/RTPM1PY6YGBL2G2R.
PubMed
Google Scholar
Marchesini G, Marzocchi R: Metabolic syndrome and NASH. Clin Liver Dis. 2007, 11 (1): 105-117. 10.1016/j.cld.2007.02.013. ix
PubMed
Google Scholar
Papandreou D, Rousso I, Mavromichalis I: Update on non-alcoholic fatty liver disease in children. Clin Nutr. 2007, 26 (4): 409-415. 10.1016/j.clnu.2007.02.002.
CAS
PubMed
Google Scholar
Pessayre D: Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007, 22 (Suppl 1): S20-27. 10.1111/j.1440-1746.2006.04640.x.
CAS
PubMed
Google Scholar
Wei Y, Rector RS, Thyfault JP, Ibdah JA: Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol. 2008, 14 (2): 193-199. 10.3748/wjg.14.193.
CAS
PubMed
PubMed Central
Google Scholar
Bolzan AD, Bianchi MS: Genotoxicity of streptozotocin. Mutat Res. 2002, 512 (2-3): 121-134. 10.1016/S1383-5742(02)00044-3.
CAS
PubMed
Google Scholar
Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF: Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA. 1977, 74 (6): 2485-2489. 10.1073/pnas.74.6.2485.
CAS
PubMed
PubMed Central
Google Scholar
Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001, 50 (6): 537-546.
CAS
PubMed
Google Scholar
Doi K: [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)]. Nippon Naibunpi Gakkai Zasshi. 1975, 51 (3): 129-147.
CAS
PubMed
Google Scholar
Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S: High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett. 2007, 246 (1-2): 115-121. 10.1016/j.canlet.2006.02.008.
CAS
PubMed
Google Scholar
de la Monte SM, Tong M, Lester-Coll N, Plater M, Wands JR: Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis. 2006, 10 (1): 89-109.
CAS
PubMed
Google Scholar
Hoyer S: Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol. 2004, 541: 135-152.
CAS
PubMed
Google Scholar
Hoyer S, Lannert H, Noldner M, Chatterjee SS: Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J Neural Transm. 1999, 106 (11-12): 1171-1188. 10.1007/s007020050232.
CAS
PubMed
Google Scholar
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM: Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis. 2006, 9 (1): 13-33.
CAS
PubMed
Google Scholar
Murata M, Takahashi A, Saito I, Kawanishi S: Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol. 1999, 57 (8): 881-887. 10.1016/S0006-2952(98)00370-0.
CAS
PubMed
Google Scholar
Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M, Kawada J: Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic beta-cells. FEBS Lett. 1988, 239 (2): 295-298. 10.1016/0014-5793(88)80938-4.
CAS
PubMed
Google Scholar
West IC: Radicals and oxidative stress in diabetes. Diabet Med. 2000, 17 (3): 171-180. 10.1046/j.1464-5491.2000.00259.x.
CAS
PubMed
Google Scholar
Robbiano L, Mereto E, Corbu C, Brambilla G: DNA damage induced by seven N-nitroso compounds in primary cultures of human and rat kidney cells. Mutat Res. 1996, 368 (1): 41-47. 10.1016/S0165-1218(96)90038-5.
CAS
PubMed
Google Scholar
Verdelho A, Madureira S, Ferro JM, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D: Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry. 2007, 78 (12): 1325-1330. 10.1136/jnnp.2006.110361.
PubMed
PubMed Central
Google Scholar
Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN: Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry. 2006, 11 (8): 721-736. 10.1038/sj.mp.4001854.
CAS
PubMed
Google Scholar
Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM: Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 2005, 8 (3): 247-268.
CAS
PubMed
Google Scholar
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM: Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?. J Alzheimers Dis. 2005, 7 (1): 63-80.
CAS
PubMed
Google Scholar
Craft S: Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007, 4 (2): 147-152. 10.2174/156720507780362137.
CAS
PubMed
Google Scholar
Craft S: Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord. 2006, 20 (4): 298-301. 10.1097/01.wad.0000213866.86934.7e.
CAS
PubMed
Google Scholar
Winocur G, Greenwood CE: Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging. 2005, 26 (Suppl 1): 46-49. 10.1016/j.neurobiolaging.2005.09.003.
PubMed
Google Scholar
Winocur G, Greenwood CE, Piroli GG, Grillo CA, Reznikov LR, Reagan LP, McEwen BS: Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci. 2005, 119 (5): 1389-1395. 10.1037/0735-7044.119.5.1389.
CAS
PubMed
Google Scholar
Weinstock M, Shoham S: Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J Neural Transm. 2004, 111 (3): 347-366. 10.1007/s00702-003-0058-y.
CAS
PubMed
Google Scholar
Nitta A, Murai R, Suzuki N, Ito H, Nomoto H, Katoh G, Furukawa Y, Furukawa S: Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol. 2002, 24 (5): 695-701. 10.1016/S0892-0362(02)00220-9.
CAS
PubMed
Google Scholar
Biju MP, Paulose CS: Brain glutamate dehydrogenase changes in streptozotocin diabetic rats as a function of age. Biochem Mol Biol Int. 1998, 44 (1): 1-7.
CAS
PubMed
Google Scholar
Haan MN: Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol. 2006, 2 (3): 159-166. 10.1038/ncpneuro0124.
CAS
PubMed
Google Scholar
Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, Degroodt W, Mehta P, Craft S: Intranasal insulin improves cognition and modulates {beta}-amyloid in early AD. Neurology. 2008, 70 (6): 440-448. 10.1212/01.WNL.0000265401.62434.36.
CAS
PubMed
Google Scholar
Landreth G: Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. Curr Alzheimer Res. 2007, 4 (2): 159-164. 10.2174/156720507780362092.
CAS
PubMed
Google Scholar
Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frolich L, Craft S: Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiol Aging. 2006, 27 (1): 38-41. 10.1016/j.neurobiolaging.2004.11.011.
CAS
PubMed
Google Scholar
Reger MA, Craft S: Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc). 2006, 42 (11): 729-739. 10.1358/dot.2006.42.11.1007675.
CAS
Google Scholar
Reger MA, Watson GS, Frey WH, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S: Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 2006, 27 (3): 451-458. 10.1016/j.neurobiolaging.2005.03.016.
CAS
PubMed
Google Scholar
Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR: Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol. 2006, 199 (2): 265-273. 10.1016/j.expneurol.2006.01.018.
CAS
PubMed
Google Scholar
Lyn-Cook LE, Lawton M, Tong M, Silbermann E, Longato L, Jiao P, Mark P, Wands JR, Xu H, de la Monte SM: Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis. J Alzheimers Dis. 2009, 16 (4): 715-729.
PubMed
PubMed Central
Google Scholar
Moroz N, Tong M, Longato L, Xu H, de la Monte SM: Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis. 2008, 15 (1): 29-44.
CAS
PubMed
Google Scholar
Gilman S, Quinn NP: The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology. 1996, 46 (5): 1197-1199.
CAS
PubMed
Google Scholar
Gilman S, Sima AA, Junck L, Kluin KJ, Koeppe RA, Lohman ME, Little R: Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol. 1996, 39 (2): 241-255. 10.1002/ana.410390214.
CAS
PubMed
Google Scholar
Burk K, Globas C, Wahl T, Buhring U, Dietz K, Zuhlke C, Luft A, Schulz JB, Voigt K, Dichgans J: MRI-based volumetric differentiation of sporadic cerebellar ataxia. Brain. 2004, 127 (Pt 1): 175-181. 10.1093/brain/awh013.
CAS
PubMed
Google Scholar
Dickson DW, Lin W, Liu WK, Yen SH: Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol. 1999, 9 (4): 721-732.
CAS
PubMed
Google Scholar
Jellinger KA, Seppi K, Wenning GK: Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005, 20 (Suppl 12): S29-36. 10.1002/mds.20537.
PubMed
Google Scholar
Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC: Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. 2005, 64 (4): 675-679.
CAS
PubMed
Google Scholar
Berciano J: Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci. 1982, 53 (2): 253-272. 10.1016/0022-510X(82)90011-9.
CAS
PubMed
Google Scholar
Mizutani T: [Neuropathological background of spinocerebellar degeneration--with special reference to autonomic nervous system lesions in olivopontocerebellar atrophy, Shy-Drager syndrome and multiple system atrophy]. No To Shinkei. 1985, 37 (7): 675-685.
CAS
PubMed
Google Scholar
Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, Tolosa E: Differential progression of brain atrophy in Parkinson disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry. 2009,
Google Scholar
Averback P, Crocker P: Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis. Arch Neurol. 1982, 39 (3): 155-156.
CAS
PubMed
Google Scholar
Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med. 1997, 38 (6): 925-928.
CAS
PubMed
Google Scholar
Larner AJ: The cerebellum in Alzheimer's disease. Dement Geriatr Cogn Disord. 1997, 8 (4): 203-209. 10.1159/000106632.
CAS
PubMed
Google Scholar
Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, Mlodzik B, De Leon MJ, Miller DC: Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res. 1999, 818 (1): 41-50. 10.1016/S0006-8993(98)01279-7.
CAS
PubMed
Google Scholar
Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K: Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol. 2003, 62 (8): 812-819.
CAS
PubMed
Google Scholar
Tu PH, Robinson KA, de Snoo F, Eyer J, Peterson A, Lee VM, Trojanowski JQ: Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J Neurosci. 1997, 17 (3): 1064-1074.
CAS
PubMed
Google Scholar
Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM, Trojanowski JQ: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology. 2004, 63 (8): 1376-1384.
CAS
PubMed
PubMed Central
Google Scholar
Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, White CL, Baker M, Hutton M: Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol. 2001, 60 (5): 403-410.
CAS
PubMed
Google Scholar
Rusina R, Bourdain F, Matej R: [Multiple system atrophy and Alzheimer's disease: a case report of a rare association of two neuro-degenerative disorders]. Rev Neurol (Paris). 2007, 163 (12): 1239-1241.
CAS
Google Scholar
Engel PA, Grunnet M: Atypical dementia and spastic paraplegia in a patient with primary lateral sclerosis and numerous necortical beta amyloid plaques: new disorder or Alzheimer's disease variant?. J Geriatr Psychiatry Neurol. 2000, 13 (2): 60-64. 10.1177/089198870001300203.
CAS
PubMed
Google Scholar
Sheridan PL, Hausdorff JM: The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007, 24 (2): 125-137. 10.1159/000105126.
PubMed
PubMed Central
Google Scholar
Thomann PA, Schlafer C, Seidl U, Santos VD, Essig M, Schroder J: The cerebellum in mild cognitive impairment and Alzheimer's disease - a structural MRI study. J Psychiatr Res. 2008, 42 (14): 1198-1202. 10.1016/j.jpsychires.2007.12.002.
PubMed
Google Scholar
Bertoni-Freddari C, Fattoretti P, Casoli T, Caselli U, Meier-Ruge W: Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer's type. Anal Quant Cytol Histol. 1996, 18 (3): 209-213.
CAS
PubMed
Google Scholar
Fukutani Y, Cairns NJ, Rossor MN, Lantos PL: Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation. J Neurol Sci. 1997, 149 (2): 177-184. 10.1016/S0022-510X(97)05399-9.
CAS
PubMed
Google Scholar
Dickson DW, Wertkin A, Mattiace LA, Fier E, Kress Y, Davies P, Yen SH: Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathol. 1990, 79 (5): 486-493. 10.1007/BF00296107.
CAS
PubMed
Google Scholar
Baloyannis SJ: Dendritic pathology in Alzheimer's disease. J Neurol Sci. 2009, 283 (1-2): 153-157. 10.1016/j.jns.2009.02.370.
CAS
PubMed
Google Scholar
Baloyannis SJ, Manolidis SL, Manolidis LS: Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study. Acta Otolaryngol. 2000, 120 (2): 247-250. 10.1080/000164800750001026.
CAS
PubMed
Google Scholar
Baloyannis SJ: Pathological alterations of the climbing fibres of the cerebellum in vascular dementia: a Golgi and electron microscope study. J Neurol Sci. 2007, 257 (1-2): 56-61. 10.1016/j.jns.2007.03.003.
PubMed
Google Scholar
Carson MJ, Slager UT, Steinberg RM: Simultaneous occurrence of diabetes mellitus, diabetes insipidus, and optic atrophy in a brother and sister. Am J Dis Child. 1977, 131 (12): 1382-1385.
CAS
PubMed
Google Scholar
de la Monte SM, Tong M, Cohen AC, Sheedy D, Harper C, Wands JR: Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration. Alcohol Clin Exp Res. 2008, 32 (9): 1630-1644. 10.1111/j.1530-0277.2008.00731.x.
CAS
PubMed
PubMed Central
Google Scholar
de la Monte SM: Insulin resistance and Alzheimer's disease. BMB Rep. 2009, 42 (8): 475-481.
CAS
PubMed
PubMed Central
Google Scholar
Giovannone B, Tsiaras WG, de la Monte S, Klysik J, Lautier C, Karashchuk G, Goldwurm S, Smith RJ: GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling. Hum Mol Genet. 2009, 18 (23): 4629-4639. 10.1093/hmg/ddp430.
CAS
PubMed
PubMed Central
Google Scholar
Busiguina S, Fernandez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I: Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis. 2000, 7 (6 Pt B): 657-665. 10.1006/nbdi.2000.0311.
CAS
PubMed
Google Scholar
Cohen AC, Tong M, Wands JR, de la Monte SM: Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model. Alcohol Clin Exp Res. 2007, 31 (9): 1558-1573. 10.1111/j.1530-0277.2007.00450.x.
CAS
PubMed
Google Scholar
de la Monte SM, Wands JR: Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis. 2005, 7 (1): 45-61.
CAS
PubMed
Google Scholar
de la Monte SM, Wands JR: Alzheimer's Disease is Type 3 Diabetes: Evidence Reviewed. J Diabetes Science Tech. 2008, 2 (6): 1101-1113.
Google Scholar
Cole G, Neal JW, Singhrao SK, Jasani B, Newman GR: The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis. Acta Neuropathol. 1993, 85 (5): 542-552. 10.1007/BF00230495.
CAS
PubMed
Google Scholar
Tong M, de la Monte SM: Mechanisms of ceramide-mediated neurodegeneration. J Alzheimers Dis. 2009, 16 (4): 705-714.
PubMed
PubMed Central
Google Scholar
Hietanen E, Bartsch H, Ahotupa M, Bereziat JC, Bussacchini-Griot V, Cabral JR, Camus AM, Laitinen M, Wild H: Mechanisms of fat-related modulation of N-nitrosodiethylamine-induced tumors in rats: organ distribution, blood lipids, enzymes and pro-oxidant state. Carcinogenesis. 1991, 12 (4): 591-600. 10.1093/carcin/12.4.591.
CAS
PubMed
Google Scholar
Alessenko AV, Bugrova AE, Dudnik LB: Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease. Biochem Soc Trans. 2004, 32 (Pt 1): 144-146. 10.1042/BST0320144.
CAS
PubMed
Google Scholar
Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH, Futerman AH: Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem. 2008, 283 (9): 5677-5684. 10.1074/jbc.M707386200.
CAS
PubMed
Google Scholar
Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F: Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem. 2008, 283 (20): 13538-13548. 10.1074/jbc.M709950200.
CAS
PubMed
PubMed Central
Google Scholar
Summers SA: Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006, 45 (1): 42-72. 10.1016/j.plipres.2005.11.002.
CAS
PubMed
Google Scholar
Adibhatla RM, Hatcher JF: Altered Lipid Metabolism in Brain Injury and Disorders. Subcell Biochem. 2008, 48: nihpa41041
Google Scholar
Katsel P, Li C, Haroutunian V: Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?. Neurochem Res. 2007, 32 (4-5): 845-856. 10.1007/s11064-007-9297-x.
CAS
PubMed
Google Scholar
Nakane M, Kubota M, Nakagomi T, Tamura A, Hisaki H, Shimasaki H, Ueta N: Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus. Neurosci Lett. 2000, 296 (2-3): 89-92. 10.1016/S0304-3940(00)01655-4.
CAS
PubMed
Google Scholar
Weiland D, Mondon CE, Reaven GM: Evidence for multiple causality in the development of diabetic hypertriglyceridaemia. Diabetologia. 1980, 18 (4): 335-340. 10.1007/BF00251016.
CAS
PubMed
Google Scholar
Lijinsky W, Reuber MD, Riggs CW: Dose response studies of carcinogenesis in rats by nitrosodiethylamine. Cancer Res. 1981, 41 (12 Pt 1): 4997-5003.
CAS
PubMed
Google Scholar
Lijinsky W, Saavedra JE, Reuber MD: Induction of carcinogenesis in Fischer rats by methylalkylnitrosamines. Cancer Res. 1981, 41 (4): 1288-1292.
CAS
PubMed
Google Scholar
Bansal AK, Bansal M, Soni G, Bhatnagar D: Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver. Chem Biol Interact. 2005, 156 (2-3): 101-111. 10.1016/j.cbi.2005.08.001.
CAS
PubMed
Google Scholar
Clapp NK, Craig AW, Toya RE: Diethylnitrosamine oncogenesis in RF mice as influenced by variations in cumulative dose. Int J Cancer. 1970, 5 (1): 119-123. 10.1002/ijc.2910050116.
CAS
PubMed
Google Scholar
Butler SM, Ashford JW, Snowdon DA: Age, education, and changes in the Mini-Mental State Exam scores of older women: findings from the Nun Study. J Am Geriatr Soc. 1996, 44 (6): 675-681.
CAS
PubMed
Google Scholar
Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR: Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA. 1996, 275 (7): 528-532. 10.1001/jama.275.7.528.
CAS
PubMed
Google Scholar
Iizuka S, Suzuki W, Tabuchi M, Nagata M, Imamura S, Kobayashi Y, Kanitani M, Yanagisawa T, Kase Y, Takeda S, Aburada M, Takahashi KW: Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Exp Anim. 2005, 54 (1): 71-83. 10.1538/expanim.54.71.
CAS
PubMed
Google Scholar
Figueroa CD, Taberner PV: Pancreatic islet hypertrophy in spontaneous maturity onset obese-diabetic CBA/Ca mice. Int J Biochem. 1994, 26 (10-11): 1299-1303. 10.1016/0020-711X(94)90099-X.
CAS
PubMed
Google Scholar
Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V: Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA. 1999, 281 (15): 1401-1406. 10.1001/jama.281.15.1401.
CAS
PubMed
Google Scholar
Dunnett SB, Fibiger HC: Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. Prog Brain Res. 1993, 98: 413-420. full_text.
CAS
PubMed
Google Scholar
Meyer PM, Strecker K, Kendziorra K, Becker G, Hesse S, Woelpl D, Hensel A, Patt M, Sorger D, Wegner F, Lobsien D, Barthel H, Brust P, Gertz HJ, Sabri O, Schwarz J: Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry. 2009, 66 (8): 866-877. 10.1001/archgenpsychiatry.2009.106.
CAS
PubMed
Google Scholar
Tong M, Dong M, de la Monte SM: Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis. 2009, 16 (3): 585-599.
CAS
PubMed
PubMed Central
Google Scholar
Chhabra SK, Souliotis VL, Kyrtopoulos SA, Anderson LM: Nitrosamines, alcohol, and gastrointestinal tract cancer: recent epidemiology and experimentation. In Vivo. 1996, 10 (3): 265-284.
CAS
PubMed
Google Scholar
Hashimoto K, Takasaki W, Sato I, Tsuda S: DNA damage measured by comet assay and 8-OH-dG formation related to blood chemical analyses in aged rats. J Toxicol Sci. 2007, 32 (3): 249-259. 10.2131/jts.32.249.
CAS
PubMed
Google Scholar
Myers SR, Ali MY: Haemoglobin adducts as biomarkers of exposure to tobacco-related nitrosamines. Biomarkers. 2008, 13 (2): 145-159. 10.1080/13547500701470561.
CAS
PubMed
Google Scholar
Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA: Lipid mediators of insulin resistance. Nutr Rev. 2007, 65 (6 Pt 2): S39-46. 10.1111/j.1753-4887.2007.tb00327.x.
PubMed
Google Scholar
Kraegen EW, Cooney GJ: Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol. 2008, 19 (3): 235-241. 10.1097/01.mol.0000319118.44995.9a.
CAS
PubMed
Google Scholar
Wang G, Silva J, Dasgupta S, Bieberich E: Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia. 2008, 56 (4): 449-456. 10.1002/glia.20626.
PubMed
Google Scholar
Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP: Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA. 2004, 101 (7): 2070-2075. 10.1073/pnas.0305799101.
CAS
PubMed
PubMed Central
Google Scholar
Han X, D MH, McKeel DW, Kelley J, Morris JC: Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem. 2002, 82 (4): 809-818. 10.1046/j.1471-4159.2002.00997.x.
CAS
PubMed
Google Scholar
Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ, Mucke L: Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res Brain Res Rev. 1997, 23 (1-2): 47-61. 10.1016/S0165-0173(96)00014-8.
CAS
PubMed
Google Scholar
Gottfries CG, Karlsson I, Svennerholm L: Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type. Int Psychogeriatr. 1996, 8 (3): 365-372. 10.1017/S1041610296002736.
CAS
PubMed
Google Scholar
Pylypiw HM, Zubroff JR, Magee PN, Harrington GW: The metabolism of N-nitrosomethylaniline. J Cancer Res Clin Oncol. 1984, 108 (1): 66-70. 10.1007/BF00390975.
CAS
PubMed
Google Scholar
Singer GM, Taylor HW, Lijinsky W: Liposolubility as an aspect of nitrosamine carcinogenicity: quantitative correlations and qualitative observations. Chem Biol Interact. 1977, 19 (2): 133-142. 10.1016/0009-2797(77)90026-6.
CAS
PubMed
Google Scholar
Hinuma K, Matsuda J, Tanida N, Hori S, Tamura K, Ohno T, Kano M, Shimoyama T: N-nitrosamines in the stomach with special reference to in vitro formation, and kinetics after intragastric or intravenous administration in rats. Gastroenterol Jpn. 1990, 25 (4): 417-424.
CAS
PubMed
Google Scholar